SCN Corporate Connect's Jane King sits down with Dan McClory, the Managing Director & Head of Equity of Boustead Securities, at the Nasdaq MarketSite to discuss Boustead's recent Reg A+ and IPO deals.
top of page
Search
Recent Posts
See AllMiami, New York and Milan, Italy – September 26, 2024 – Boustead Securities, LLC (“Boustead”) client Brera Holdings PLC (“Brera...
160
Irvine, CA – September 19, 2024 - Boustead client Reticulate Micro, Inc. ("Reticulate Micro"), a commercial and defense technology...
100
Irvine, CA — September 18, 2024 – Boustead Securities, LLC (“Boustead”) client Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”)...
90
bottom of page
Comments